Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 25-Jun-14 8:32 PM View:  | Weiser Michael Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 450,178 | -- | -- | (100%) 450.18K to 0 | |
| 25-Jun-14 8:34 PM View: | Rueckert William Dodge Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 15,000 | -- | -- | (100%) 15.0K to 0 | |
| 25-Jun-14 8:37 PM View: | Hewitt L Arthur Chief Scientific Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 218,923 | -- | -- | (79%) 277.61K to 58.68K | |
| 25-Jun-14 8:26 PM View: | Roberts Michael J VP, Business Development | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 109,878 | -- | -- | (83%) 131.88K to 22.0K | |
| 25-Jun-14 8:26 PM View: | Roberts Michael J VP, Business Development | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 22,000 | -- | -- | (100%) 22.0K to 0 | |
| 25-Jun-14 8:23 PM View: | Oliveto Joseph President and CEO Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 490,000 | -- | -- | (99%) 493.5K to 3.5K | |
| 25-Jun-14 8:20 PM View: | Riehle J Nick Chief Financial Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 66,183 | -- | -- | (100%) 66.18K to 0 | |
| 25-Jun-14 8:32 PM View: | Weiser Michael Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 27,500 | $6.50 | $178,750.00 | 6% 450.18K to 477.68K | (7%) |
| 25-Jun-14 8:18 PM View: | Schwieterman William D Chief Medical Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 350,000 | -- | -- | (73%) 480.59K to 130.59K | |
| 25-Jun-14 8:30 PM View: | Clemens Kevan Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 25-Jun-14 8:37 PM View: | Hewitt L Arthur Chief Scientific Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 218,923 | $1.73 | $379,578.00 | 373% 58.68K to 277.61K | |
| 25-Jun-14 8:26 PM View: | Roberts Michael J VP, Business Development | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 109,878 | $0.91 | $99,906.00 | 499% 22.0K to 131.88K | |
| 25-Jun-14 8:23 PM View: | Oliveto Joseph President and CEO Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 490,000 | $2.00 | $980,000.00 | 14000% 3.5K to 493.5K | |
| 25-Jun-14 8:39 PM View: | Stoll Roger G Phd Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 40,000 | -- | -- | (100%) 40.0K to 0 | |
| 25-Jun-14 8:32 PM View: | Weiser Michael Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 27,500 | -- | -- | (6%) 477.68K to 450.18K | |
| 25-Jun-14 8:34 PM View: | Rueckert William Dodge Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 35,000 | -- | -- | (70%) 50.0K to 15.0K | |
| 25-Jun-14 8:18 PM View: | Schwieterman William D Chief Medical Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 350,000 | $2.98 | $1,041,450.00 | 268% 130.59K to 480.59K | |
| 25-Jun-14 8:18 PM View: | Schwieterman William D Chief Medical Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 130,592 | -- | -- | (100%) 130.59K to 0 | |
| 25-Jun-14 8:37 PM View: | Hewitt L Arthur Chief Scientific Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 58,683 | -- | -- | (100%) 58.68K to 0 | |
| 25-Jun-14 8:20 PM View: | Riehle J Nick Chief Financial Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition | 368,923 | -- | -- | (85%) 435.11K to 66.18K | |
| 25-Jun-14 8:20 PM View: | Riehle J Nick Chief Financial Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Option Exercise | 368,923 | $2.75 | $1,015,580.00 | 557% 66.18K to 435.11K | |
| 25-Jun-14 8:23 PM View: | Oliveto Joseph President and CEO Director | Chelsea Therapeutics Intern... (CHTP) | 23-Jun-14 | Disposition (change in control) | 3,500 | -- | -- | (100%) 3.5K to 0 | |
| 18-Dec-12 2:55 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 17-Dec-12 | Market Sale | 439,308 | $0.92 | $402,055.00 | (6%) 6.87M to 6.43M | (423%) |
| 18-Dec-12 2:55 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 14-Dec-12 | Market Sale | 249,249 | $0.95 | $236,811.00 | (4%) 7.12M to 6.87M | (404%) |
| 14-Dec-12 11:15 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 12-Dec-12 | Market Sale | 399,414 | $1.05 | $419,385.00 | (5%) 7.52M to 7.12M | (356%) |
| 11-Dec-12 11:35 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 10-Dec-12 | Market Sale | 139,653 | $1.05 | $146,636.00 | (2%) 7.66M to 7.52M | (356%) |
| 11-Dec-12 11:35 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 07-Dec-12 | Market Sale | 230,407 | $1.00 | $230,522.00 | (3%) 7.89M to 7.66M | (379%) |
| 07-Dec-12 3:00 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 06-Dec-12 | Market Sale | 235,009 | $1.07 | $251,460.00 | (3%) 8.13M to 7.89M | (348%) |
| 07-Dec-12 3:00 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 05-Dec-12 | Market Sale | 154,836 | $1.18 | $182,706.00 | (2%) 8.28M to 8.13M | (306%) |
| 06-Jun-12 5:01 PM View: | Weiser Michael Director | Chelsea Therapeutics Intern... (CHTP) | 05-Jun-12 | Market Purchase | 5,000 | $1.32 | $6,599.51 | 1% 445.18K to 450.18K | 263% |
| 05-Jun-12 4:55 PM View: | Lau Johnson Yiu Nam Director | Chelsea Therapeutics Intern... (CHTP) | 04-Jun-12 | Market Purchase | 8,000 | $1.31 | $10,480.00 | 267% 3.0K to 11.0K | 266% |
| 30-Jan-12 9:30 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 27-Jan-12 | Market Purchase | 21,900 | $4.46 | $97,721.60 | < 1% 16.58M to 16.61M | 47% |
| 24-Jan-12 10:41 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 23-Jan-12 | Market Purchase | 40,000 | $4.80 | $192,000.00 | < 1% 8.24M to 8.28M | (< 1%) |
| 27-Jan-12 5:42 PM View: | Stoll Roger G Phd Director | Chelsea Therapeutics Intern... (CHTP) | 30-Dec-11 | Gift | 12,000 | -- | -- | (23%) 52.0K to 40.0K | |
| 15-Dec-11 4:19 PM View: | Weiser Michael Director | Chelsea Therapeutics Intern... (CHTP) | 06-Dec-11 | Exercise (in-the money or at-the-money) | 18,593 | $2.88 | $53,547.80 | 4% 426.58K to 445.18K | |
| 28-Nov-11 4:43 PM View: | Schwieterman William D Chief Medical Officer | Chelsea Therapeutics Intern... (CHTP) | 23-Nov-11 | Market Purchase | 45,141 | $4.46 | $201,329.00 | 53% 85.45K to 130.59K | 7% |
| 19-Oct-11 11:09 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 17-Oct-11 | Market Purchase | 2,100 | $4.37 | $9,177.00 | < 1% 8.24M to 8.24M | 10% |
| 15-Jun-11 1:59 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 14-Jun-11 | Market Sale | 20,018 | $4.89 | $97,817.70 | (< 1%) 8.26M to 8.24M | 2% |
| 15-Jun-11 1:59 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 13-Jun-11 | Market Sale | 49,420 | $4.61 | $227,777.00 | (< 1%) 8.31M to 8.26M | (4%) |
| 09-Mar-11 4:13 PM View: | Schwieterman William D Chief Medical Officer | Chelsea Therapeutics Intern... (CHTP) | 07-Mar-11 | Market Purchase | 40,000 | $3.96 | $158,400.00 | 88% 45.45K to 85.45K | 21% |
| 15-Feb-11 2:07 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 11-Feb-11 | Exercise (in-the money or at-the-money) | 120,000 | $4.20 | $504,000.00 | 1% 8.19M to 8.31M | |
| 04-Feb-11 5:32 PM View: | Venrock Healthcare Capital ... 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 02-Feb-11 | Market Purchase | 75,000 | $5.00 | $374,992.00 | 1% 5.11M to 5.19M | (4%) |
| 05-Nov-10 10:00 PM View: | Riehle J Nick Chief Financial Officer | Chelsea Therapeutics Intern... (CHTP) | 04-Nov-10 | Market Purchase | 3,000 | $4.83 | $14,490.00 | 5% 63.18K to 66.18K | < 1% |
| 22-Sep-10 5:14 PM View: | Venrock Healthcare Capital ... 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 20-Sep-10 | Market Sale | 99,000 | $6.30 | $623,650.00 | (3%) 3.68M to 3.58M | 23% |
| 07-Sep-10 8:22 AM View: | Pedder Simon Chief Executive Officer Director | Chelsea Therapeutics Intern... (CHTP) | 02-Sep-10 | Market Purchase | 1,250 | $4.08 | $5,100.00 | < 1% 486.93K to 488.18K | 19% |
| 16-Aug-10 3:49 PM View: | Oliveto Joseph Vice President of Operations | Chelsea Therapeutics Intern... (CHTP) | 12-Aug-10 | Market Purchase | 3,500 | $2.87 | $10,045.00 | 100% 0 to 3.5K | 69% |
| 12-Aug-10 2:05 PM View: | Roberts Michael J VP, Business Development | Chelsea Therapeutics Intern... (CHTP) | 11-Aug-10 | Market Purchase | 2,000 | $3.10 | $6,200.00 | 10% 20.0K to 22.0K | 56% |
| 11-Jun-10 11:05 AM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 09-Jun-10 | Market Purchase | 100,000 | $2.97 | $296,790.00 | 1% 8.09M to 8.19M | 63% |
| 11-Jun-10 4:31 PM View: | Rueckert William Dodge Director | Chelsea Therapeutics Intern... (CHTP) | 08-Jun-10 | Market Purchase | 15,000 | $3.00 | $45,000.00 | 60% 25.0K to 40.0K | 62% |
| 08-Jun-10 12:31 PM View: | Austin Josiah T 10% Owner | Chelsea Therapeutics Intern... (CHTP) | 04-Jun-10 | Market Purchase | 10,000 | $3.19 | $31,900.00 | < 1% 8.08M to 8.09M | 52% |
